Data / Form D filings / Axxess Compounding LLLP
Axxess Compounding LLLP: Form D filings
Axxess Compounding LLLP, a pharmaceuticals company in Pacific Palisades, CA, filed 3 Form D notices with the SEC between 2013 and 2014. The latest, on November 7, 2014, reports $457,500 sold of a $25 million offering to 34 investors.
Find out what Axxess Compounding LLLP does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 15332 ANTIOCH ST, SUITE 548, Pacific Palisades, CA, 90272
- Phone
- (406) 219-7512
- Industry
- Pharmaceuticals
- Entity type
- Limited Partnership
- Incorporated in
- Montana
- Year incorporated
- 2011
- Revenue range
- No Revenues
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1584530
The full lists. Form D filings in California: 5,891 rows, $138.91, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Nov 7, 2014 | Amendment | $25,000,000 | $457,500 | $24,542,500 | 34 | Aug 6, 2013 | sec.gov |
| Jan 9, 2014 | Amendment | $690,000 | $240,000 | $450,000 | 3 | Aug 6, 2013 | sec.gov |
| Aug 16, 2013 | New notice | $470,000 | $25,000 | $445,000 | 3 | Aug 6, 2013 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Francis X Riegler | Director |
Other pharmaceuticals companies in California that filed recently
- Anvion Bio, Inc. $100,000 · Oct 7, 2026
- Aqur Biosciences, Inc. $1.5 million · Sep 18, 2026
- BTB Therapeutics, Inc. $8.9 million · Aug 12, 2026
Every Form D from the week of Nov 3, 2014 · All recent filings in California · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Axxess Compounding LLLP reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.